Quince Therapeutics, Inc. Common Stock (NASDAQ: QNCX) last traded at $31.73, up 8.07% on the session. The quote above updates while this page is open; the figures below are drawn from Quince Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Quince Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker QNCX. Its market capitalisation is $32.27 million.
Valuation measures for Quince Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $32.27M |
|---|---|
| Enterprise value | -$68.20M |
| Beta | 1.90 |
Trailing-twelve-month figures tagged in Quince Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$92.48M |
|---|---|
| Cash |
|---|
| $115.98M |
Range and volume for QNCX over the past 52 weeks.
| 52-week high | $910.00 |
|---|---|
| 52-week low | $15.10 |
| Volume | 138.7K |
| Average volume | 30.5K |
| Previous close | $29.36 |
Invest a chosen dollar amount in Quince Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell QNCX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.